Inspire Medical Systems I... (INSP)
Inspire Medical Systems Inc. (INSP) Stock Price, Analysis & Data
| Bid | 57 |
| Market Cap | 1.68B |
| Revenue (ttm) | 898.74M |
| Net Income (ttm) | 135.04M |
| Beta | 0.67 |
| EPS (ttm) | 4.46 |
| PE Ratio (ttm) | 13.07 |
| Forward PE | 37.92 |
| P/B (ttm) | 2.04 |
| P/S (ttm) | 1.87 |
| Earnings Date | Nov 2, 2026 |
| Ask | 58.61 |
| Volume | 489,341 |
| Avg. Volume (20D) | 1,046,516 |
| Open | 58.03 |
| Previous Close | 59.13 |
| Day's Range | 57.20 - 59.12 |
| 52-Week Range | 38.91 - 147.03 |
| Analyst | Hold |
| Price Target | 60 (2.95%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About INSP
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously m...
Financial Performance
In 2025, Inspire Medical Systems's revenue was 911.98M, an increase of 13.6% compared to the previous year's 802.8M. Earnings were 145.42M, an increase of 171.77%.
Financial StatementsAnalyst Forecast
According to 15 analyst ratings, the average rating for INSP stock is "Hold". The 12-month stock price forecast is 60, which is upside of 2.95% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
